T cell abnormalities in NZB mice occur independently of autoantibody production by unknown
T  CELL  ABNORMALITIES  IN  NZB  MICE  OCCUR 
INDEPENDENTLY  OF  AUTOANTIBODY  PRODUCTION 
BY JOEL D. TAUROG,* ELIZABETH S. RAVECHE, PATRICIA A. SMATHERS, 
LAURIE H. GLIMCHER, DAVID P. HUSTON,:~ CARL T. HANSEN, AND 
ALFRED D. STEINBERG§ 
From the Arthritis and Rheumatism Branch, and Laborato~ of Experimental Pathology, National Institute 
of Arthritis, Metabolism, and Digestive Diseases; Laborato~ of Immunology, National Institute of Allergy 
and Infectious lh'seases; Veterina~ Resource Branch, Division of Researvh Services, National Institutes of 
Health, Bethesda, Maolland 20205 
New Zealand Black (NZB) 1 mice spontaneously develop an autoimmune disease 
characterized by autoantihodies to erythrocytes, T  lymphocytes, and nucleic acids. 
Death due to hemolytic anemia, lymphoid malignancy, or immune complex nephritis 
occurs at a mean of 15-18 mo of age (1-4). Both the B and T  cell populations of NZB 
mice have been shown  to manifest  abnormal  immune  functions  (2-18).  However, 
NZB mice spontaneously produce IgM anti-T cell antibodies beginning early in life 
(19-22). Moreover, such antibodies preferentially interact with, and eliminate, sup- 
pressor ceils (23-26). Thus, anti-T cell antibodies, the products of B cells, have been 
postulated to bring about T  cell abnormalities in NZB mice (21-26). 
CBA/N mice bear an X-linked gene (xid) which results in the lack of a subpopu- 
lation of B cells that normally appears late in ontogeny (27-44). We (38)  and others 
(39)  have demonstrated that  the xid is completely expressed in CBA/N  ×  NZB F1 
males.  However, other workers have reported autoantibody production by CBA/N 
X  NZB  males  (45).  Unfortunately, the contribution to the full expression of NZB 
autoimmune  disease  of the  B  cell subset  controlled by xid cannot  be explored in 
CBA/N ×  NZB F1 hybrids because these mice, as well as female CBA/N ×  NZB and 
male NZB  x  CBA/N  mice, produce only low levels of autoantibodies,  and  live a 
normal  life span  of 2  yr or more  (A.  D.  Steinberg and J.  P.  Reeves, unpublished 
observations). Therefore, to explore adequately the natural history ofxid-bearing NZB 
mice, we have studied congenic mice bearing the xid on an NZB background. Study 
of these mice has permitted us to shed further light on the pathogenesis of autoim- 
munity in NZB mice. Furthermore, because such mice failed to produce autoantibod- 
ies, we were able to study T  cell function in the absence of autoantibody production. 
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Such studies indicate that  the  T  cell defects of NZB  mice occur independently of 
autoantibody production. 
Materials and Methods 
Mice.  NZB/N,  CBA/N,  DBA/2N,  and  BALB/c  mice were  obtained from  the  Animal 
Production  Facilities, National Institutes of Health,  Bethesda,  Md.  C56BL/6J  mice were 
obtained from The Jackson Laboratory, Bar Harbor, Maine. ZB.CBA/N congenic mice were 
bred by the following scheme: a male offspring of a CBA/N ×  NZB cross was backcrossed to 
its mother. The female offspring of this cross was mated with an NZB male. A male from this 
mating was backcrossed with its mother and the female offspring crossed with an NZB male to 
produce a male. This process was continued. In every mating after the first, all mice had only 
X chromosomes from CBA/N mice; this minimized the possibility of crossover in the region of 
xid on the X chromosome. The experiments reported here were performed on males and females 
obtained after 8-12 crosses and backcrosses. Such mice contained X chromosomes derived only 
from CBA/N mice, but had about 90% NZB autosomal genes. An identically bred congenic 
line, D2.CBA/N, employing DBA/2 mice (instead of NZB mice) as the background strain, was 
concurrently produced. 
Antibody Response to rI.rC  Mice were immunized intraperitoneally with 100 #g rI.rC (P-L 
Biochemicals, Inc., Milwaukee, Wis.)  in saline without adjuvant; they were  bled 4  d  later. 
Antibody to  rI.rC  was  assayed  as  previously described  (40,  41).  Briefly,  50 #l  serum was 
incubated at 37°C for 30 min and then at 4°C overnight with 28 ng [l*C]rI.rC (1.8 nCi/#g, 
Miles Laboratories, Inc., Kankakee, Ill.); ammonium sulfate was then added to 35% saturation, 
and radioactivity counted in the supernatant fluid after centrifugation. This 4-d antibody 
response to rI. rC has been previously shown to be absent in CBA/N-defective mice (31, 38). 
Assay of IgM.  Culture supernatant fluids and serum sample were assayed for IgM levels by 
solid  phase  radioimmunoassay, as  previously described  (38). Briefly,  flexible roundbottom 
microtiter plates were coated with 10 #g/ml afflnity-purified  rabbit anti-mouse Ig in phosphate- 
buffered saline (PBS). Dilutions of Igi  myeloma standard or test serum or supernatant fluid 
in PBS containing  0.5% rabbit serum albumin were added for 3 h. The plates were rinsed, then 
incubated with 3H-labeled rabbit anti-mouse #-chain (38) for 3 h, rinsed, and individual wells 
counted for 3H. Some serum IgM levels were determined by radial immunodiffusion  with plates 
and standards purchased from Meloy Laboratories, Springfield, Va. 
In  Vitro Spleen Cell Culture.  Single cell suspensions of individual spleens were washed three 
times through fetal calf serum (FCS), then cultured in replicate 1-ml aliquots containing 107 
nucleated cells in modified Mishell-Dutton medium, as previously described (38). Precuhure 
and 4-h culture supernatant fluids were then assayed for IgM content. 
Direct  Coombs' Test for  Antie~ythrocyte Antibodies and  Hematocrit  Determinations.  Heparinized 
erythrocytes were washed and assayed for  agglutination with serial dilutions of sheep anti- 
mouse Ig serum, as previously described (14, 38). Known positive and negative controls were 
included in each assay and gave expected results. 
Hematocrits were determined by centrifugation of heparinized blood in capillary tubes and 
direct measurement of percentage of packed erythrocyte volume. 
Assay of Antithymocyte Antibodies.  Spontaneously occurring antibodies to T cells were assayed 
4  51  as previously described (46). 5 ×  10  Cr-labeled C56BL/6 thymocytes were incubated with a 
1:5 dilution of each serum in RPMI-1640 (Grand Island Biological Co., Grand Island, N. Y.) 
containing 10% FCS for 45 min at 4°C, washed three times, and incubated for 30 min at 37°C 
with a  1:5 dilution of selected,  thymocyte-adsorbed rabbit complement (Cappel Laboratories, 
Cochranville, Pa). Supernatant fluids were counted for 51Cr release in a gamma spectrometer. 
Maximum release was determined by repeated freezing and thawing of labeled cells. Known 
positive and negative controls were run in each assay and gave expected results. Percent killing 
was calculated: 
Experimental release  -  (medium +  C) release 
% killing =  100 x 
Maximum release  -  (medium +  C) release 
Assay ofanti-DNA Antibodies.  Mice were bled at various ages and the serum was heated for TAUROG ET AL.  223 
30 min at 56°C, then assayed in a Farr assay as previously described (40).  25 #1 of serum was 
incubated overnight with  15  ng of native or single-stranded human  [aH]DNA (0.24  #Ci/#g; 
Electronucleonics, Bethesda, Md.); ammonium sulfate was then added to 35% saturation, and 
radioactivity was counted in the supernatant  fluid after centrifugation. Known positive and 
negative controls were run in each assay and gave expected results. 
Cytogenetic Analysis.  Animals  were  killed  by  cervical  dislocation,  and  the  spleens  were 
removed and weighed. Chromosomal analysis was carried out as previously described (47).  A 
single spleen cell suspension  was  prepared  in  Hanks'  balanced salt solution  (HBSS),  then 
centrifuged and resuspended in 0.075 M KCI for 30 min. The swollen cells were then centrifuged 
and  resuspended in  a  3:1  methanol:glacial acetic fixative for  10  min,  then  resuspended in 
fixative and prepared on slides. Slides were stained for  15  min  in,a 4%  Giemsa solution in 
Gurr's buffer (pH 6.8) and metaphase chromosomes were counted at high power by ordinary 
light  microscopy. At  least  30  metaphase  cells per spleen were  examined.  Aneuploidy was 
indicated by -->5% of the cells bearing abnormal chromosome numbers. 
C-banding was  accomplished by  incubating  fixed cells on  slides in  0.2  N  HC!  at  room 
temperature for 1 h, rinsing, then incubating in 0.05 N Ba(OH)2 for 90 s at room temperature 
and then in 0.3 M  NaCI, containing 0.03 M  sodium citrate, at 60°C for 1 h. After rinsing, the 
slides were stained in 4% Giemsa solution for 1 rain, dried, and examined. 
Induction of Tolerance to Bovine Gammaglobulin (BGG).  As previously described (9), DEAE- 
purified bovine gammaglobulin BGG was uhracentrifuged at  100,000 g for 1 h; the top one- 
third of this preparation was used to give 10 mg tolerizing doses i.p. to mice. 10 d later, mice 
were challenged with 0.5 mg BGG in complete Freund's adjuvant (CFA) (Difco Laboratories, 
Detroit,  Mich.)  and  subsequently bled at  10  and  30  d  after challenge. Assay of anti-BGG 
antibodies was  performed  as  previously described  (9).  Briefly, dilutions of serum  in  PBS, 
containing 0.5%  rabbit serum albumin, were incubated in microtiter wells previously coated 
with BGG, 10 #g/ml in PBS. After rinsing, the wells were incubated with affinity-purified 3H- 
rabbit anti-mouse Ig (9, 38), then rinsed and individually counted for 3H (9, 38). The antibody 
response of tolerized and challenged mice was expressed as a percentage of the response of mice 
not tolerized, hut challenged. 
Allogeneic Mixed Lymphocyte Culture.  Cultures were performed as described (48). Single spleen 
cell suspensions  from  responder  and  stimulator cells were  prepared  in  HBSS.  Stimulator 
C56BL/6 cells were exposed to 2,000 rad of gamma irradiation. 1 ×  107 responder cells and 1 
×  10  e irradiated stimulator cells were cultured for 96 h  in  16-ram flatbottom culture wells in 
1.5 mi of modified Mishell-Dutton medium containing 10% FCS in a humidified atmosphere 
of 10% COz, 7% Ch, and 83% N2. 
Cell-mediated Lympholysis.  EL-4  tumor  cells  (H-2  b)  were  maintained  and  labeled  with 
51  4  Na2  CrO4 as described (48). Cytotoxicity was assayed as described (48). Briefly, 5 ×  10  labeled 
tumor target cells and 1 ×  106 washed, viable effector cells from the 96-h primary culture were 
incubated together in 0.2 ml Eagle's Minimum Essential Medium containing 10% FCS for 4 h 
at 37°C in a humidified atmosphere containing 5% CO2. SlCr release and percent specific lysis 
were determined as described under Assay of Antithymoeyte Antibodies. 
Autologous Mixed Lymphocyte Reaction (MLR).  The ability of T cells to respond to autologous 
non-T ceils was tested as described previously (49). Lymph node T cells, 4 ×  10  ~, were cultured 
with 1 ×  10  ~ irradiated peritoneal cells in RPMI-1640 containing 5% polyethylene glycol, 5 × 
10  -5 M  2-mercaptoethanol, and 0.5% syngeneic mouse serum for 5 d at 37°C in a humidified 
atmosphere containing 5% CO2. Tritiated thymidine incorporation was determined during the 
last 24 h. All experiments were run in triplicate and repeated on two separate occasions. 
Results 
Survival.  Our  original  ZB.CBA/N  mice  have  now  all  lived  at  least  2  yr.  An 
additional 30 male and 30 female ZB.CBA/N mice have been observed for >18 mo; 
none  has  died of autoimmune  disease or malignancy.  In  marked  contrast  to  NZB 
mice, there appears to be no decrease in the lifespan of the ZB.CBA/N mice compared 
with nonautoimmune  mice. 
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and  10  4-mo-old NZB  females were injected with rI,rC  and bled 4  d  later.  Neither 
the  ZB.CBA/N  males  nor  females made  a  significant antibody  response to  rI. rC, 
whereas  the  NZB  mice  made  their expected substantial  response  (Table  I).  Thus, 
ZB.CBA/N  mice,  like  all  other  CBA/N-defective  mice  studied,  fail  to  produce 
antibody to a  single injection of rI-rC, a  TI-2 T-independent  antigen. 
TABLE  I 
Antibody  Response to rl. rC* 
Percent [14C]ri.  rC 
Strairr  Sex  Number  bound 
Mean ± SEM 
ZB.CBA/N  M  7  8. i +  4.9 
F  18  3.7 ±  2.8 
NZB  F  10  61.2 ±  8.4 
* 4-mo-old mice were injected with  100/zg of rI.rC and bled 4 d  later.  The 
percentage of 28 ng [14C]rI.rC bound by 50 #1 of serum was determined. 
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Ft6.  1.  ZB.CBA/N male mouse obtained after 12 crosses and backcrosses was mated with NZB 
female, and the female offspring (NZB x ZB.CBA/N) were mated with an NZB male. The resulting 
34 mice were studied for serum IgM concentration. For comparison, results are shown of studies of 
20 ZB.CBA/N mice of both sexes and 20 NZB  mice of both sexes, both expressed  as means with 
vertical  bars denoting the standard errors. 
TABLE  II 
Secretion of IgM by Spleen Cells during 4 h In  Vitro 
Strain  IgM secretion  in ng/107 celts 
Mean "+ SEM 
ZB.CBA/N  < 1 
NZB  1,750 ±  240 
BALB/c  150 ±  41 
Spleen cells from 6-8-wk-old female mice, three mice per group, were individ- 
ually  cultured for 4 h at 37°C in modified MishelI-Dutton medium. The net 
secretion of IgM in the supernates was measured by immunoradiometric assay. TAUROG  ET  AL.  225 
Serum IgM Levels and In  Vitro Spleen Cell IgM Secretion.  Two Z~B.CBA/N males were 
mated with NZB females. The female offspring were then mated with  NZB males, 
and these offspring were tested for serum IgM levels at 4-5 wk of age.  Because the 
(NZB  ×  ZB.CBA/N)F1  females have one normal X  chromosome and one CBA/N- 
defective X  chromosome, one would  expect  half of the  male offspring of (NZB  X 
ZB.CBA/N)F1  female ×  NZB male backcross and  none of the  female offspring to 
demonstrate the xid phenotype. The results confirm this prediction, as shown in Fig. 
1. Of 34 backcrossed mice, 10 of 19 males and none of 15 females had low IgM levels. 
Control  ZB.CBA/N  and  NZB  mice  showed  expected  low  and  high  IgM  levels, 
respectively. 
In a  separate experiment, spleen cells of ZB.CBA/N, BALB/c, and NZB females 
were cultured  for 4 h  in vitro and secreted IgM assayed. The ZB.CBA/N mice, like 
the other CBA/N-defective mice we have studied, secreted no detectable IgM in 4-h 
spleen cell culture (Table II). 
Antie~ythrocyte Antibodies in  ZB.CBA/N Mice.  ZB.CBA/N  and  control  NZB  mice 
were assessed periodically for spontaneously occurring antierythrocyte autoantibodies. 
In addition,  hematocrits were determined both in the ZB.CBA/N and control NZB 
mice. A  few ZB.CBA/N  mice of various ages displayed  transient,  low-titer positive 
responses in the Coombs' assay; these were markedly lower than those of NZB mice 
(Fig.  2).  Further, whereas NZB mice older than 9  mo were anemic, the ZB.CBA/N 
mice had normal hematocrits even at 22 mo of age (Fig. 3). 
Spontaneous Anti-T Cell Antibodies in ZB.CBA/N Mice.  Sera from male ZB.CBA/N 
and NZB mice were assayed at a  1:5 dilution for complement-dependent cytotoxicity 
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Flo.  2.  The geometric mean of the reciprocal of the titers of antibodies to autologous erythrocytes 
(measured by the direct Coombs test) are indicated for NZB and ZB.CBA/N mice at various ages. 
Standard errors are  indicated by  the  vertical bars.  The  fraction above each  point  indicates the 
number of mice with a  titer ->1:4  (i.e.,  a  reciprocal titer of 2 or more)  over the number of mice 
studied at that age. Different mice were analyzed at different ages. 226  PATHOGENESIS  OF  NZB  DISEASE 
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Flc.  3.  The means and standard errors of the hematocrits of NZB and ZB.CBA/N mice at various 
ages are shown. Different mice were studied at different ages. 
TABLE  III 
Spontaneous Antithymocyte Antibodies in ZB. CBA/N Mice 
Number posi-  Percent 51Cr re- 
Strain  Age  tive/total  lease 
ZB.CBA/N 
NZB 
,no  Mean ± SEM 
11-12  0/4  6 ±  6 
13"  0/3  0 ±  0 
17*  0/6  4  ±  4 
4-5  18/20  71 ±  9 
11-13  16/17  79 4- 8 
Male ZB.CBA/N and NZB mice of various ages were bled and the comple- 
ment-dependent cytotoxicity for ~lCr-tabeled C57B 1/6 thymocytes was meas- 
ured at a  1:5 dilution of serum. Groups of prepubertally castrated mice are 
designated by an asterisk (*). A positive result is >50% 51Cr release at a  1:5 
serum dilution. 
against 51Cr-labeled C56BL/6  thymocytes. The  ZB.CBA/N  sera contained  no signif- 
icant antibody,  in marked  contrast  to the control  NZB  sera  (Table  III).  Prepubertal 
castration  had  no effect on the cytotoxic activity of ZB.CBA/N  serum  (Table III). 
Spontaneous  Antibodies to DNA in ZB.CBA/N Mice.  Male  ZB.CBA/N  and  NZB  mice 
of varying  ages  were  bled  and  the  sera  were  assayed  for  spontaneously  occurring 
antibodies  binding  native  or single-stranded  [3H]DNA  (Table  IV).  The  ZB.CBA/N 
mice  showed  insignificant  serum  binding  of either  single-stranded  DNA  or  native TAUROG  ET  AL.  227 
TABLE  IV 
Spontaneous Antibodies to DATA in ZB.CBA/N Mice 
Strain  Age  Number 
Mean percent [SH]DNA 
bound ±  SEM 
Single-  Native 
stranded 
ZB.CBA/N 
NZB 
mo 
7  12  2±2  2±  1 
15  4  3±2  7±  1 
17"  3  8z1:3  10±3 
22*  5  18 ±  3  4 ±  3 
7  12  54 ±  5  ND:[: 
7*  13  65 ±  5  ND~ 
12  18  ND:]:  39 ±  6 
* Male  ZB.CBA/N and  NZB mice of various ages were  bled and  the serum  was 
assayed  for  antibodies binding native or  single-stranded DNA  in  a  Farr  assay 
employing 25  ng of DNA and 25 #l of serum.  Prepubertally castrated mice are 
designated by an asterisk (*). 
1: ND, not done. 
TABLE V 
Spleen Weights of ZB.CBA/N and NZB Mice 
Strain  Sex  Number  Spleen weight 
mg 
NZB  F  20  861 ±  184 
NZB  M  7  393 ±  115 
ZB.CBA/N  F  5  74 ±  13 
ZB.CBA/N  M  5  68 ±  10 
Spleens of ZB.CBA/N and NZB mice 9-12 mo of age were weighed immedi- 
ately after removal from the peritoneal cavity. 
TABLE  VI 
Aneuploidy in Spleen Cells of ZB.CBA/ N Mice 
Strain  Sex  Number showing aneu- 
ploidy/total 
NZB  F  16/20 
NZB  M  4/7 
ZB.CBA/N  F  0/5 
ZB.CBA/N  M  0/5 
Spleen cells from ZB.CBA/N and NZB mice, 9-12 mo old, were swollen,  fixed, 
and prepared on Giemsa-stained slides. Metaphase chromosomes were counted. 
Aneuploid spleens showed >5% cells with extra chromosomes. 
DNA,  compared  with  NZB  serum  binding.  Prepubertally  castrated  mice  tended  to 
show slightly higher DNA  binding  than  did intact mice  (Table IV). 
Cytogenetic  Analysis.  ZB.CBA/N  and  NZB  mice 9-12  mo old were killed and  their 
spleens were weighed,  minced,  and  fixed for cytogenetic analysis. Table  V  shows the 
spleen weights;  NZB  spleens weighed  -6  and  12 times more  than  the corresponding 
male and  female ZB.CBA/N  spleens, respectively. 
Each spleen was examined  for the presence of aneuploid cells. At least 30 metaphases 228  PATHOGENESIS  OF  NZB  DISEASE 
TABLE  VII 
Mitotic Index of Spleen Cells in ZB.CBA/N and NZB Mice 
Strain  Mitotic cells/100 nucleated spleen 
cells 
NZB  4.3 +  1.5 
ZB.CBA/N  0.13 +  0.06 
Spleens from three female mice of each strain, age 9  mo, were analyzed for 
mitotic cells. 
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FIG.  4.  Antibody  responses  to  challenge  with  BGG  in  CFA  are  shown  for  mice  receiving  a 
tolerizing dose of BGG 10 d  before challenge. The data are presented as the geometric mean of the 
anti-BGG titer expressed as the percentage of the responses of their respective nontolerized controls. 
The  top  bar  of each  pair  represents  the  anti-BGG  titer  10  d  after  challenge;  the  bottom  bar 
represents the titer 30 d  after challenge. The NZB and ZB.CBA/N mice failed to become tolerant, 
whereas the DBA/2 and D2.CBA/N mice were tolerant. Four-way t test analysis indicated that the 
differences between NZB and DBA/2 mice were highly significant (P <  0.01) as were the differences 
between  ZB.CBA/N  and  D2.CBA/N,  whereas  there  was  no  significant  difference  between 
ZB.CBA/N and NZB mice. This experiment was repeated on two occasions with similar results. 
TABLE  VIII 
Accelerated Killing of Allogeneic Targets by NZB and ZB. CBA/N Spleen 
Cells in Prima~y Culture 
Strain  Net lysis 
% 
NZB  42 +  3 
ZB.CBA/N  38 +  5 
D2.CBA/N  3 •  1 
DBA/2  14 :~ 3 
BALB/c  8 +  3 
Responder  strain  spleen  cells  (107) were  cultured  with  1  ×  106  irradiated 
C57BL/6 spleen cells for 4 d and then assayed for killing of EL-4 tumor target 
cells in  a  4-h 5~Cr-release assay.  Each  number represents the  mean of two 
separate  spleens.  Responder  mice  were  3-mo-old  females.  Results  of  two 
experiments are combined here. TAUROG  ET  AL.  229 
TABLE  IX 
Autologous MLR in l-yr-OM Mice 
Strain  Mean cpm ±  SEM 
(x 10  -3) 
NZB  15.7 ±  3.3 
ZB.CBA/N  22.0 ±  5.2 
CBA/N  93.8 ±  4.2 
Nylon  wool-nonadherent  lymph  node  cells,  4  ×  l0  b,  were  cultured  with 
irradiated peritoneal cells for 5 d, and [aH]thymidine incorporation during the 
last  24  h  of culture was measured. Data  represent means of three separate 
experiments. 
were examined from each spleen. Aneuploid cells were common in NZB spleens, but 
absent  from ZB.CBA/N spleens  (Table VI).  The number of mitotic cells was  also 
greatly  increased  in  NZB  mice,  whereas  the  ZB.CBA/N  mice  showed  relatively 
normal numbers of mitotic cells (Table VII).  Finally, ZB.CBA/N spleen cells were 
examined by C-banding and found to show the reduced centromeric heterochromatics 
characteristic of one NZB  autosomal  chromosomal  pair  and  can  be considered a 
marker for NZB cells (47). 
Induction of Tolerance to BGG.  ZB.CBA/N, NZB, DBA/2, and D2.CBA/N mice, 6- 
12  wk  old,  were  injected  with  10  mg  ultracentrifuged  BGG  and  subsequently 
challenged with 0.5 nag BGG in CFA, along with nontolerized controls, and bled for 
antibodies to BGG. ZB.CBA/N mice were as resistant to tolerance induction as NZB 
mice. This contrasts with the results found in DBA/2  and D2.CBA/N  mice which 
demonstrated  normal  tolerance induction.  The results of a  typical experiment are 
shown in Fig. 4. 
Cell-mediated Lympholysis after Primary Allogeneic Mixed Lymphocyte Culture.  NZB mice 
develop an accelerated cytotoxic response to allogenic cells in primary in vitro culture 
(16).  To  test  ZB.CBA/N  mice  for  this  property,  NZB,  ZB.CBA/N,  DBA/2,  and 
D2.CBA/N spleen cells were cultured for 4 d  with irradiated C56BL/6 spleen cells, 
and  subsequently  assayed  for ability  to  kill  51Cr-labeled  EL-4  tumor  cell  targets. 
ZB.CBA/N  mice  demonstrated  the  accelerated cytotoxicity characteristic  of NZB 
mice (Table VIII). 
Autologous Mixed Lymphocyte Culture.  In contrast to that of nonautoimmune mice, 
the proliferative response of NZB T  lymphocytes in an autologous mixed lymphocyte 
culture diminishes markedly with age (49).  1-yr-old ZB.CBA/N, NZB, and CBA/N 
female mice were studied in an autologous MLR. The ZB.CBA/N mice, like the NZB 
mice but  unlike the CBA/N  and  other nonautoimmune strains previously studied 
(49), showed only a weak proliferative response (Table IX). 
Discussion 
The studies reported herein document a striking abrogation of the development of 
autoimmunity in NZB mice by the introduction of the CBA/N X chromosome-linked 
defect (xid). Excessive IgM production, autoantibody production, splenomegaly, and 
splenic aneuploidy, as well as reduced survival, were not present in these ZB.CBA/N 
congenic mice. Thus, although these mice were largely NZB genetically, they failed 
to demonstrate any of the B cell-mediated abnormalities usually associated with the 230  PATHOGENESIS OF NZB DISEASE 
autoimmune  state  in  NZB  mice.  Especially  striking  were  the  lack  of antibody 
production to erythrocytes, T  cells, and DNA, and the normal survival. 
As  noted  in  the  introduction,  it  has  been  previously postulated  that  the  T  cell 
abnormalities reported in NZB mice might not represent primary abnormalities in 
the T  cell population, but rather result from the action of anti-T cell autoantibodies 
produced by B cells.  The eongenic ZB.CBA/N mice have provided a  unique oppor- 
tunity to examine this question. In particular, these mice are largely NZB genetically, 
and yet they produce no anti-T cell antibodies. We found that such mice manifest the 
T  cell abnormalities characteristic of NZB  mice. In three separate assays of T  cell 
function, the congenic mice were abnormal; these results suggest strongly that all of 
the T  cell abnormalities of NZB mice cannot be attributable to B cell products, e.g., 
anti-T cell antibodies. Instead, it appears that NZB mice have, in addition to primary 
B cell abnormalities, primary T  cell abnormalities. 
The  studies  reported  here  were  performed  on  "congenic"  mice  that  were  not 
completely inbred.  It  might  be argued  that  further baekcrossing would eventually 
permit the development of autoantibodies. This is unlikely because most of the genes 
regulating autoantibody production are expressed in Fx and/or backcross mice which 
contain, respectively, 50 and  75% of the NZB autosomal genes (7, 41, 50-58). Thus 
the proportion of autosomal NZB genes in the mice studied was sufficient to permit 
expression of autoantibody production. The lack of such production is best explained 
by the xid, which prevents the development of a  subset of B cells that is apparently 
critical for the development of autoimmunity in NZB mice. Furthermore, C-banding 
of chromosomes from the least backcrossed of the mice studied demonstrated complete 
expression of the reduced centromeric staining of one autosomal pair that is charac- 
teristic of NZB mice (47). This finding makes highly unlikely the theoretical possibility 
that a  high degree of autosomal recombination might have occurred and thus have 
resulted in a preponderance of CBA/N autosomal genes. 
In the present study, we have assumed that the lack of development of autoimmune 
disease in NZB mice carrying the CBA/N X  chromosome is causally related to the 
presence of xid. It is, of course, possible that some other region of the X  chromosome 
of CBA/N  mice is responsible for the results observed. This could occur if genetic 
material on the NZB X chromosome not allelic to xid is necessary for the development 
of autoimmunity. This possibility is extremely unlikely in view of reciprocal backcross 
studies which indicate no necessity for the NZB X  chromosome in the development 
of autoantibodies  (41). Moreover, we have observed that castrated DBA/2  ×  NZB 
males (which lack an NZB X  chromosome) are capable of producing both anti-T cell 
and anti-single-stranded DNA antibodies (58). 
Genetic studies by a  number of investigators have shown that separate autoanti- 
bodies are produced under separate genetic controls  (7,  50,  57-60).  Further, aneu- 
ploidy seen in older NZB spleen cells represents an independent autosomal recessive 
trait  (47).  Despite these differing autosomal  genetic systems, the xid was  found to 
prevent all of these abnormalities. Thus, the B cell subset controlled by xid represents 
a critical pathway of spontaneous autoantibody production in NZB mice. 
Summary 
By means of a  series of crosses and  backcrosses, ZB.CBA/N  mice were prepared 
bearing largely NZB autosomal genes, but having X  chromosomes derived only from TAUROG ET AL.  231 
CBA/N mice. The CBA/N X  chromosome carries a gene, xid, that is associated with 
the  lack  of a  B  cell  subset  necessary  for  most  of the  spontaneous  autoantibody 
production by NZB mice. These ZB.CBA/N mice failed to develop autoantibodies to 
T  cells,  erythrocytes, or DNA. The availability of mice that were mostly NZB, but 
which failed to make autoantibodies, especially anti-T cell antibodies, allowed us to 
study possible T cell regulatory defects in NZB mice in the absence of  either antibodies 
reactive with  such T  cells  or other autoantibodies.  We  found  that  such  mice  had 
derangements of T  cell regulation as did the NZB mice. These observations strongly 
suggest  that  the  T  cell  abnormalities  of NZB  mice  are  not  caused  by  the  B  cell 
hyperactivity of these  mice,  but  rather  represent  independent  defects.  Thus,  NZB 
mice appear to have primary defects in  both the  B cell  population and  the T  cell 
population. Whether or not these are separate, or derive from a  common precursor 
cell abnormality, remains to be determined. 
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